You are on page 1of 4

UPH654: KNOW YOUR MEDICINE

CASE STUDY

STUDENT DETAILS
FACULTY FACULTY OF PHARMACY

GROUP PH2402A

NAME AIMAN BIN MOHD NAZIR

STUDENT ID 2020627932
Name of the subject Mr. OA

Age 82 Years Old

Weight: 105 kg
Weight/Height
Height: 1.68 m
BMI: 37.20

1. Bisoprolol fumarate 2.5mg


2. Trimetazidine dihydrochloride 35mg
3. Pantoprazole sodium sesquihydrate
40mg
Past & current medication list 4. Atorvastatin 40mg
5. Aspirin 100mg
6. Calcitriol 0.25mcg
7. Calcium carbonate 500mg
8. Glyceryl trinitrate 0.5 mg

Marital status : Widower


Children(s) : Two
Smoking : No

Social history Drinking status : No


Occupation : Pensioner (Previously
served as waiter in
MINDEF)

1. Cardiovascular disease
Past & current medical condition 2. Osteoporosis
3. Prostate cancer
Generic name of medicine Nitroglycerin

Brand name of medicine Myonit Insta

Used to relieve chest pain (angina) in


Specific indication of the medicine people that have a certain heart condition
(coronary artery disease)

Strength of the medicine 0.5mg/tab

Dose of the medicine 1 tablet (0.5mg) taken when necessary.

1. Put one tablet underneath the tongue


Instruction on how to take medicine and let it dissolved slowly.
2. Repeat as needed not more than 3
tablets within 15 minutes.

Formulation of the medicine Solid (tablet)

Route of administration Sublingual

Registration number MAL10120035AZ

1. Store below 30°C.


2. Store in a dry place and protect from
Medicine storage light.
3. Keep the lid tightly closed.
4. Disposed after 8 weeks of opening the
bottle.

Contraindicated in patients with:


- early myocardial infarction
Contraindications - severe anemia
- increased intracranial pressure
- known hypersensitivity to nitroglycerin.

- Headache that may be severe and


persistent may occur immediately
after use.
- Vertigo, dizziness, weakness,
Adverse reactions palpitation, and other manifestations
of postural hypotension may develop
occasionally, particularly in erect,
immobile patients.

Use in pregnancy and lactation - Does not have specific studies on the
use in pregnancy and lactation.

Shape of medicine Round tablets


Color of medicine White

Photo of the medicine

REFERENCES

1. National Pharmaceutical Regulatory Agency (NPRA). (2015). ‘NITROGLYCERIN 0.5MG


SUBLINGUAL TABLET’. Retrieved at 10th May 2021 from:
https://www.npra.gov.my/index.php/en/consumers/information/consumer-medication-
information-leaflets-rimup.raw?task=callelement&item_id=2242&element=73072a74-
677b-422f-b029-25562bd71d81&method=download
2. RxList. (2020). ‘Nitrostat’. Retrieved at 10th May 2021 from:
https://www.rxlist.com/nitrostat-drug.htm#description
3. Drugs.com. (2019). ‘Nitroglycerin Pregnancy and Breastfeeding Warnings’. Retrieved at
12th May 2021 from: https://www.drugs.com/pregnancy/nitroglycerin.html
4. Kyle et al. (2020). ‘Nitroglycerin’. Retrieved at 12th May 2021 from:
https://www.ncbi.nlm.nih.gov/books/NBK482382/
5. Mayo Clinic. (2021). ‘Nitroglycerin (Oral Route, Sublingual Route)’. Retrieved at 12th May
2021 from: https://www.mayoclinic.org/drugs-supplements/nitroglycerin-oral-route-
sublingual-route/proper-use/drg-20072863
6. emc. (2019). ‘Glyceryl Trinitrate Tablets 500 micrograms’. Retrieved at 12th May 2021
from: https://www.medicines.org.uk/emc/product/5827/smpc#gref

You might also like